Press releases
- Press releases
- Browse
Press releases
Alizyme PLC has received approval from the UK Medicines Control Agency for a Phase III clinical trial to assess efficacy and safety of COLAL-PREDTM for maintaining remission in patients with ulcerative colitis. More
Alizyme PLC has obtained positive preliminary results in a Phase II clinical trial with COLAL-PREDTM in ulcerative colitis patients with active disease. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jan 2008 - 148 pages - $1,740
Nov 2010 - 119 pages - $1,495
Aug 2010 - $15,200
Mar 2011 - 32 pages - $5,700
Aug 2011 - 81 pages - $3,835
Dec 2010 - 71 pages - $500
Apr 2011 - 69 pages - $1,000
Aug 2011 - 107 pages - $1,000
Sep 2011 - 69 pages - $3,800
Jul 2006 - 240 pages - $3,500
Your selection
Browse By
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us